JP2023518419A5 - - Google Patents
Info
- Publication number
- JP2023518419A5 JP2023518419A5 JP2022556043A JP2022556043A JP2023518419A5 JP 2023518419 A5 JP2023518419 A5 JP 2023518419A5 JP 2022556043 A JP2022556043 A JP 2022556043A JP 2022556043 A JP2022556043 A JP 2022556043A JP 2023518419 A5 JP2023518419 A5 JP 2023518419A5
- Authority
- JP
- Japan
- Prior art keywords
- brequinal
- pharmaceutical composition
- sodium
- approximately
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992720P | 2020-03-20 | 2020-03-20 | |
| US62/992,720 | 2020-03-20 | ||
| US202063020460P | 2020-05-05 | 2020-05-05 | |
| US63/020,460 | 2020-05-05 | ||
| US202063030677P | 2020-05-27 | 2020-05-27 | |
| US63/030,677 | 2020-05-27 | ||
| US202063043382P | 2020-06-24 | 2020-06-24 | |
| US202063043386P | 2020-06-24 | 2020-06-24 | |
| US202063043388P | 2020-06-24 | 2020-06-24 | |
| US202063043384P | 2020-06-24 | 2020-06-24 | |
| US63/043,384 | 2020-06-24 | ||
| US63/043,388 | 2020-06-24 | ||
| US63/043,386 | 2020-06-24 | ||
| US63/043,382 | 2020-06-24 | ||
| PCT/US2021/023350 WO2021189017A1 (en) | 2020-03-20 | 2021-03-19 | Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518419A JP2023518419A (ja) | 2023-05-01 |
| JP2023518419A5 true JP2023518419A5 (enExample) | 2024-03-28 |
Family
ID=77771654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556043A Pending JP2023518419A (ja) | 2020-03-20 | 2021-03-19 | ブレキナルナトリウムの安定した多形性組成物ならびにその使用および製造方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4121050A4 (enExample) |
| JP (1) | JP2023518419A (enExample) |
| AU (1) | AU2021236757A1 (enExample) |
| CA (1) | CA3175964A1 (enExample) |
| WO (1) | WO2021189017A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022159763A1 (en) * | 2021-01-22 | 2022-07-28 | Model Medicines, Inc. | Sars-cov-2 therapeutics |
| WO2023043830A1 (en) * | 2021-09-15 | 2023-03-23 | Clear Creek Bio, Inc. | Combination therapies to treat viral infections |
| CN120131690A (zh) * | 2025-03-24 | 2025-06-13 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一种布喹那在制备抑制流感病毒的制剂中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05011525A (es) * | 2003-04-30 | 2005-12-12 | Nippon Shinyaku Co Ltd | Cristales de solvato de derivado de acido quinolincarboxilico. |
| CA2910112C (en) * | 2013-04-25 | 2021-02-16 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| US11096934B2 (en) * | 2015-09-01 | 2021-08-24 | The Broad Institute, Inc. | Compounds and methods useful for treating or preventing hematological cancers |
| EP3773579A4 (en) * | 2018-03-26 | 2022-03-09 | Clear Creek Bio, Inc. | COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE |
| US20190290634A1 (en) * | 2018-03-26 | 2019-09-26 | Clear Creek Bio, Inc. | Compositions and methods for inhibiting dihydroorotate dehydrogenase |
| WO2019246603A1 (en) * | 2018-06-22 | 2019-12-26 | Ohio State Innovation Foundation | Methods and compositions for inhibition of dihydroorotate dehydrogenase |
-
2021
- 2021-03-19 AU AU2021236757A patent/AU2021236757A1/en active Pending
- 2021-03-19 CA CA3175964A patent/CA3175964A1/en active Pending
- 2021-03-19 EP EP21770978.1A patent/EP4121050A4/en active Pending
- 2021-03-19 WO PCT/US2021/023350 patent/WO2021189017A1/en not_active Ceased
- 2021-03-19 JP JP2022556043A patent/JP2023518419A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518419A5 (enExample) | ||
| TWI332500B (en) | Novel compounds | |
| WO2020020267A1 (zh) | 一种取代的多环性吡啶酮化合物及其前药 | |
| JP2020517611A5 (enExample) | ||
| JP2022526438A5 (enExample) | ||
| ZA200204285B (en) | Heterocyclo-alkylsulfonyl pyrazole derivatives as antiinflammatory/analgesic agents. | |
| WO2009056029A1 (en) | Purification method of pemetrexed salts,sodium salts and disodium salts | |
| JP2020521732A5 (enExample) | ||
| JP2008535848A5 (enExample) | ||
| BRPI0111140B1 (pt) | Forma polimórfica, uso da mesma, e, composição farmacêutica | |
| FI3781562T3 (fi) | P300:n ja/tai cbp:n modulaattorien valmistusmenetelmä | |
| JP2022523368A5 (enExample) | ||
| JP2002538165A5 (enExample) | ||
| WO2013185301A1 (zh) | 黄酮及二氢黄酮衍生物在制备镇静、催眠药物中的用途 | |
| TW201900639A (zh) | 一種苯并呋喃類衍生物游離鹼的晶型及製備方法 | |
| JP2025511277A5 (enExample) | ||
| CN115518058A (zh) | N-环烷基取代的芳甲胺类化合物在制备抗病毒药物中的用途及结构和制备方法 | |
| TW219329B (enExample) | ||
| JPH11506772A (ja) | 抗ウイルス化合物 | |
| KR101536488B1 (ko) | 이미다졸 유도체, 그의 제조 방법 및 용도 | |
| CN103193864A (zh) | 培哚普利的精氨酸盐的δ晶型、其制备方法和包含它的药物组合物 | |
| JP2012526054A (ja) | 複素環置換のジフェニル尿素類誘導体及びその用途 | |
| TW200817014A (en) | 3'-ethynylcytidine derivative | |
| JP2025511331A5 (enExample) | ||
| JP2020512975A5 (enExample) |